These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 8464875)

  • 21. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.
    Shen L; Potter TA; Kane KP
    J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific epitope-induced conversion of CD8+ memory cells into effector cytotoxic T lymphocytes in vitro: presentation of peptide antigen by CD8+ T cells.
    Kos FJ; Müllbacher A
    Eur J Immunol; 1992 Jun; 22(6):1595-601. PubMed ID: 1376266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigen presentation in syrian hamster cells: substrate selectivity of TAP controlled by polymorphic residues in TAP1 and differential requirements for loading of H2 class I molecules.
    Lobigs M; Müllbacher A; Blanden RV; Hämmerling GJ; Momburg F
    Immunogenetics; 1999 Oct; 49(11-12):931-41. PubMed ID: 10501835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHC.
    Neeley YC; McDonagh KT; Overwijk WW; Restifo NP; Sanda MG
    Prostate; 2002 Nov; 53(3):183-91. PubMed ID: 12386918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccinia-interleukin 2 recombinant virus or exogenous interleukin 2 does not alter the magnitude or immune response gene defects of the cytotoxic T-cell response to vaccinia virus in vivo.
    Müllbacher A; Ramshaw IA; Coupar BE
    Scand J Immunol; 1989 Jan; 29(1):1-6. PubMed ID: 2493675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule.
    Chen BP; Madrigal A; Parham P
    J Exp Med; 1990 Sep; 172(3):779-88. PubMed ID: 2117634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
    Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I
    J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine transporter associated with antigen presentation (TAP) preferences influence class I-restricted T cell responses.
    Yellen-Shaw AJ; Laughlin CE; Metrione RM; Eisenlohr LC
    J Exp Med; 1997 Nov; 186(10):1655-62. PubMed ID: 9362526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.
    Carbone FR; Moore MW; Sheil JM; Bevan MJ
    J Exp Med; 1988 Jun; 167(6):1767-79. PubMed ID: 2455012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and T cell recognition of hybrid antigens with amino-terminal domains encoded by Qa-2 region of major histocompatibility complex and carboxyl termini of transplantation antigens.
    Stroynowski I; Forman J; Goodenow RS; Schiffer SG; McMillan M; Sharrow SO; Sachs DH; Hood L
    J Exp Med; 1985 May; 161(5):935-52. PubMed ID: 2580938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E3/19K from adenovirus 2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class I proteins.
    Jefferies WA; Burgert HG
    J Exp Med; 1990 Dec; 172(6):1653-64. PubMed ID: 2147948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal tolerance of major histocompatibility complex antigens alters Ir gene control of the cytotoxic T cell response to vaccinia virus.
    Müllbacher A; Blanden RV; Brenan M
    J Exp Med; 1983 Apr; 157(4):1324-38. PubMed ID: 6220111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza A virus-specific H-2d restricted cross-reactive cytotoxic T lymphocyte epitope(s) detected in the hemagglutinin HA2 subunit of A/Udorn/72.
    Saikh KU; Martin JD; Nishikawa AH; Dillon SB
    Virology; 1995 Dec; 214(2):445-52. PubMed ID: 8553546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
    Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
    Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition of a sequestered self peptide by influenza virus-specific CD8+ cytolytic T lymphocytes.
    Fan R; Tykodi SS; Braciale TJ
    J Immunol; 2000 Feb; 164(4):1669-80. PubMed ID: 10657609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
    Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.